276702-52-4 Usage
Uses
Used in Chemical Synthesis:
2,6-dichloro-3-nitrobenzene-1-sulfonic acid is utilized as an intermediate in the synthesis of various dyes, pigments, and pharmaceuticals. Its unique chemical structure allows it to serve as a building block for the creation of a wide range of colorants and medicinal compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 2,6-dichloro-3-nitrobenzene-1-sulfonic acid is used as a key intermediate for the production of certain drugs. Its reactivity and functional groups make it a valuable component in the synthesis of pharmaceuticals with specific therapeutic properties.
Used in Dye and Pigment Industry:
2,6-dichloro-3-nitrobenzene-1-sulfonic acid is employed as a precursor in the manufacture of dyes and pigments. Its chemical properties contribute to the color intensity and stability of the final products, which are used in various applications such as textiles, plastics, and printing inks.
Used in Research and Development:
2,6-dichloro-3-nitrobenzene-1-sulfonic acid is also used in research and development settings to explore new chemical reactions and syntheses. Its unique structure provides opportunities for scientists to investigate novel applications and potential improvements in existing processes.
Safety Considerations:
Due to its potential to cause skin and eye irritation, 2,6-dichloro-3-nitrobenzene-1-sulfonic acid should be handled with appropriate safety measures, including the use of personal protective equipment and proper disposal methods to minimize environmental and health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 276702-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,6,7,0 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 276702-52:
(8*2)+(7*7)+(6*6)+(5*7)+(4*0)+(3*2)+(2*5)+(1*2)=154
154 % 10 = 4
So 276702-52-4 is a valid CAS Registry Number.
276702-52-4Relevant academic research and scientific papers
Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor
McCleland, Brent W.,Davis, Roderick S.,Palovich, Michael R.,Widdowson, Katherine L.,Werner, Michelle L.,Burman, Miriam,Foley, James J.,Schmidt, Dulcie B.,Sarau, Henry M.,Rogers, Martin,Salyers, Kevin L.,Gorycki, Peter D.,Roethke, Theresa J.,Stelman, Gary J.,Azzarano, Leonard M.,Ward, Keith W.,Busch-Petersen, Jakob
, p. 1713 - 1717 (2007/10/03)
N,N′-diarylsquaramides were prepared and evaluated as antagonists of CXCR2. The compounds were found to be potent and selective antagonists of CXCR2. Significant differences in SAR was observed relative to the previously described N,N′-diarylurea series. As was the case in the N,N′-diarylurea series, placing sulfonamide substituent adjacent to the acidic phenol significantly reduced the clearance in rat pharmacokinetic studies.
Il-8 receptor antagonists
-
, (2008/06/13)
This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
Il-8 receptor antagonists
-
, (2008/06/13)
This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists
-
, (2008/06/13)
Novell IL-8 compounds and methods of using them are provided.
